Stocks
Applied Molecular Transport Financial Statements (AMTI) |
||||||||||
| Applied Molecular Transportsmart-lab.ru | % | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 07.11.2022 | 09.03.2023 | 11.05.2023 | 14.08.2023 | 09.11.2023 | 09.11.2023 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||
| Operating Income, bln rub | -25.5 | -23.1 | -28.5 | -17.7 | -7.22 | -76.5 | ||||
| EBITDA, bln rub | ? | -25.5 | -23.1 | -11.0 | -1.47 | -7.22 | -42.8 | |||
| Net profit, bln rub | ? | -24.9 | -22.1 | -26.8 | -17.3 | -6.94 | -73.1 | |||
| OCF, bln rub | ? | -19.6 | -14.8 | -19.3 | -21.5 | -4.40 | -60.0 | |||
| CAPEX, bln rub | ? | 0.223 | 0.006 | 0.061 | 0.385 | 0.000 | 0.452 | |||
| FCF, bln rub | ? | -19.8 | -14.8 | -19.4 | -21.9 | -4.40 | -60.5 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 25.5 | 23.1 | 19.7 | 9.60 | 7.26 | 59.7 | ||||
| Cost of production, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| R&D, bln rub | 18.2 | 14.4 | 13.0 | 2.56 | 0.250 | 30.2 | ||||
| Interest expenses, bln rub | 0.321 | 0.393 | 0.579 | 0.000 | 0.000 | 0.972 | ||||
| Assets, bln rub | 124.6 | 107.4 | 83.3 | 25.0 | 20.0 | 20.0 | ||||
| Net Assets, bln rub | ? | 78.4 | 60.8 | 36.1 | 20.6 | 16.2 | 16.2 | |||
| Debt, bln rub | 36.6 | 36.1 | 35.0 | 1.71 | 1.35 | 1.35 | ||||
| Cash, bln rub | 76.0 | 61.1 | 41.8 | 22.5 | 18.1 | 18.1 | ||||
| Net debt, bln rub | -39.5 | -25.0 | -6.73 | -20.7 | -16.8 | -16.8 | ||||
| Ordinary share price, rub | 0.973 | 0.420 | 0.320 | 0.258 | 0.157 | 0.140 | ||||
| Number of ordinary shares, mln | 38.9 | 39.0 | 39.2 | 39.3 | 39.8 | 39.8 | ||||
| Market cap, bln rub | 38 | 16 | 13 | 10 | 6 | 6 | ||||
| EV, bln rub | ? | -2 | -9 | 6 | -11 | -11 | -11 | |||
| Book value, bln rub | 78 | 61 | 36 | 21 | 16 | 16 | ||||
| EPS, rub | ? | -0.64 | -0.57 | -0.68 | -0.44 | -0.17 | -1.84 | |||
| FCF/share, rub | -0.51 | -0.38 | -0.49 | -0.56 | -0.11 | -1.52 | ||||
| BV/share, rub | 2.01 | 1.56 | 0.92 | 0.52 | 0.41 | 0.41 | ||||
| FCF yield, % | ? | -281.7% | -598.0% | -675.9% | -747.7% | -969.2% | -1 087% | |||
| ROE, % | ? | -170.3% | -206.2% | -303.3% | -441.2% | -450.4% | -450.4% | |||
| ROA, % | ? | -107.2% | -116.7% | -131.6% | -365.0% | -365.5% | -365.5% | |||
| P/E | ? | -0.28 | -0.13 | -0.11 | -0.11 | -0.09 | -0.08 | |||
| P/FCF | -0.35 | -0.17 | -0.15 | -0.13 | -0.10 | -0.09 | ||||
| P/BV | ? | 0.48 | 0.27 | 0.35 | 0.49 | 0.38 | 0.34 | |||
| EV/EBITDA | ? | 0.01 | 0.07 | -0.06 | 0.17 | 0.25 | 0.26 | |||
| Debt/EBITDA | 0.30 | 0.20 | 0.07 | 0.34 | 0.39 | 0.39 | ||||
| R&D/CAPEX, % | 8 178% | 240 667% | 21 292% | 664.4% | 6 689% | |||||
| Applied Molecular Transport shareholders | ||||||||||
